Skip to content
Meta-analysis Open access

Evidence for a dose–response association of hyperuricemia with stroke incidence: a meta-analysis of cohort studies

Aug 2026 · Frontiers in Neurology · Vol 17 · 0 citations · 49 references
Medicine

TL;DR

Hyperuricemia is associated with increased risks of stroke incidence and mortality, especially in women and ischemic stroke, and a J shaped dose–response relationship was observed for stroke incidence, but not for stroke mortality.

Abstract

Background Uric acid is considered a potential risk factor for stroke; However, whether the association between hyperuricemia and stroke outcomes follows a linear or nonlinear pattern remains unclear. Therefore, this study conducted a dose–response meta-analysis based on cohort studies to investigate the association between hyperuricemia and stroke outcomes. Methods We systematically searched PubMed, the Cochrane Library, Embase, Web of Science, CNKI, Wanfang, VIP, and the Chinese Biomedical Literature Database from inception to April 2026. Cohort studies reporting the associations of uric acid with stroke incidence and mortality outcomes were included. Dose–response meta-analyses were performed by generalized least-squares estimation and restricted cubic splines with three knots located at the 10th, 50th, and 90th percentiles. Results A total of 25 cohort studies involving 1,300,263 participants were included. Conventional meta-analysis showed that hyperuricemia was significantly associated with stroke incidence (RR = 1.20, 95%CI: 1.11–1.29) and mortality (RR = 1.36, 95%CI: 1.17–1.58). Subgroup analysis indicated that hyperuricemia significantly increased the risks of stroke incidence (RR = 1.22, 95%CI: 1.08–1.38) and mortality (RR = 1.42, 95%CI: 1.15–1.77) among women. Regarding stroke subtype, hyperuricemia was significantly associated with the incidence (RR = 1.21, 95%CI: 1.03–1.42) and mortality (RR = 1.23, 95%CI: 1.01–1.49) of ischemic stroke. A J shaped dose–response relationship was found between uric acid and stroke incidence (p = 0.0023), with risk rising across uric acid levels from104 to 764.5 μmol/L and a nadir at 225 μmol/L, whereas no significant nonlinear relationship was observed for stroke mortality. Conclusion Hyperuricemia is associated with increased risks of stroke incidence and mortality, especially in women and ischemic stroke. A J-shaped dose–response relationship was observed for stroke incidence, but not for stroke mortality. Monitoring uric acid levels and their longitudinal changes may be valuable in stroke prevention strategies. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420261394403, identifier PROSPERO (CRD420261394403).

Read PDF

Similar papers

Meta-analysis Open access Sep 2026

Long-term glycemic variability and risk of peripheral artery disease: a systematic review and meta-analysis of cohort studies

Background A systematic review and meta-analysis to evaluate the impact of long-term glucose variability (GV) on the risk of developing peripheral artery disease (PAD). Methods The protocol was prospectively registered in PROSPERO (ID: CRD420251148763). Relevant longitudinal studies were identified through comprehensiv...

Jie Xia, Qiong-Hui Peng, Lei Chen et al. · 0 citations
Meta-analysis Open access Jul 2026

Risk of stroke in SLE: a systematic review and meta-analysis

Abstract The association between SLE and composite stroke, ischaemic stroke and haemorrhagic stroke remains incompletely understood. This meta-analysis aims to assess the risk of stroke in patients with SLE. Methods Data sources included PubMed, Embase, the Cochrane Library and reference lists of included studies. This...

Jing-Ya Zhang, Wei-Man Shi, Ya-Ling Xu et al. · 0 citations
Review Aug 2026

Comparative risk of new-onset diabetes between pravastatin and commonly used statins: A systematic review and meta-analysis.

IntroductionStatin therapy has been associated with an increased risk of new-onset diabetes mellitus (NODM). This systematic review and meta-analysis compared the risk of NODM between pravastatin and two commonly used statins.MethodsWe searched PubMed/MEDLINE, EMBASE, CENTRAL, and ClinicalTrials.gov from inception to M...

Harmanjit Singh, Gurleen Kaur, P. Kaushal · 0 citations
Review Sep 2026

Antidiabetic drug exposure and risk of bladder cancer: A systematic review and meta-analysis.

BACKGROUND Type 2 diabetes mellitus (T2DM) is associated with an increased risk of bladder cancer, but the impact of specific antidiabetic drug classes remains uncertain. METHODS We conducted a systematic review and meta-analysis following PRISMA guidelines. PubMed/MEDLINE, Embase, Scopus and CENTRAL were searched th...

W. Mathez, A. Vincentelli, I. Chaoui et al. · 0 citations
Review Open access Aug 2026

Serum Lipoprotein(a) and Hemorrhagic Stroke Risk: A Systematic Review and Meta-Analysis.

Post-event studies reported higher circulating Lp(a) levels in hemorrhagic stroke, but this evidence was at serious risk of bias and should be regarded as hypothesis-generating.

Maria-Ioanna Stefanou, Evangelos Panagiotopoulos, Aikaterini Theodorou et al. · 0 citations
Meta-analysis Aug 2026

The Association of Serum Calcium Levels with the Risk of Metabolic Syndrome: A Meta-Analysis of Observational Studies.

Elevated serum calcium may be associated with an increased risk of MetS, with a possibly more pronounced effect suggested in older adults, and a potential association between elevated serum calcium and increased MetS risk, which may follow a nonlinear, threshold-like pattern.

Mi Tian, Jing-Jie Luan, Xue Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.